Sign in
Taking people in United StatesNo phase

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Key facts

Who runs it
University of Vermont
Where
Burlington, United StatesSee the site
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
5 Feb 2026
Expected to end
22 Jul 2027
Type of study
Interventional
Treatments tested
  • Prolonged exposure therapy + incentives for therapy session attendance
Record updated
13 May 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Female
  • >18 years old
  • Gestational age ≤ 25 weeks
  • Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5
  • Participants receiving psychotropic medications must be maintained on a stable dose for >14 days prior to enrollment

Who cannot take part

  • Current delusions or hallucinations, unstable bipolar disorder, imminent risk for suicide as assessed by the Mini International Neuropsychiatric Interview
  • Under 18 years old
  • Gestational age > 25 weeks
  • Male
  • No current diagnosis of PTSD
  • Enrolled in another ongoing evidence-based treatment for PTSD

This trial is currently available in United States.

  • University of VermontBurlington, United StatesContact: Kelly PeckTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:

Read full original descriptionShow less

Does PE+ decrease PTSD symptoms?

All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.

Participants will:

* Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

The group in the trial

  • Prolonged exposure therapy + incentives for therapy session attendanceTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 May 2026